Volume 10, Number 4—April 2004
Letter
Mycobacterium tuberculosis Complex Drug Resistance in Italy
Table
Tested MTB strains | No history of previous treatment |
History of previous treatment |
||||
---|---|---|---|---|---|---|
No. | % | 95% CI | No. | % | 95% CI | |
Total tested |
2,117 |
100 |
– |
322 |
100 |
– |
Fully sensitive |
1,847 |
87.2 |
85.8 to 88.6 |
155 |
48.1 |
42.7 to 53.6 |
Any drug |
270 |
12.7 |
11.4 to 14.2 |
167 |
51.8 |
46.4 to 57.3 |
INH |
75 |
3.5 |
2.8 to 4.4 |
17 |
5.3 |
3.2 to 8.2 |
RMP |
17 |
0.8 |
0.5 to 1.3 |
14 |
4.3 |
2.5 to 7.0 |
EMB |
10 |
0.5 |
0.2 to 0.8 |
1 |
0.3 |
0.02 to 1.5 |
SM |
93 |
4.3 |
3.6 to 5.3 |
14 |
4.3 |
2.5 to 7.0 |
Resistant to both INH and RMP |
8 |
0.40 |
0.8 to 0.7 |
24 |
7.5 |
4.9 to 10.7 |
Resistant to INH, RMP, EMB |
2 |
0.10 |
0.01 to 0.3 |
19 |
6.0 |
3.7 to 8.9 |
Resistant to INH, RMP, SM |
6 |
0.30 |
0.1 to 0.6 |
23 |
7.1 |
4.7 to 10.4 |
Resistant to INH, RMP, EMB, SM | 7 | 0.30 | 0.1 to 0.6 | 32 | 9.9 | 7.0 to 13.5 |
aMTB, Mycobacterium tuberculosis complex; CI, confidence interval; INH, isoniazid; RMP, rifampicin; EMB, ethambutol; SM, streptomycin.
Page created: February 09, 2011
Page updated: February 09, 2011
Page reviewed: February 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.